Xponance’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,865
Closed -$1.1M 1707
2025
Q4
$1.1M Buy
10,865
+602
+6% +$48.3K 0.01% 667
2025
Q3
$561K Sell
10,263
-224
-2% -$11.2K ﹤0.01% 924
2025
Q2
$557K Sell
10,487
-14,485
-58% -$736K ﹤0.01% 910
2025
Q1
$1.08M Buy
24,972
+959
+4% +$48.6K 0.01% 665
2024
Q4
$1.35M Buy
24,013
+2,264
+10% +$141K 0.01% 622
2024
Q3
$1.48M Buy
21,749
+173
+0.8% +$9.76K 0.01% 595
2024
Q2
$912K Buy
21,576
+799
+4% +$44K 0.01% 700
2024
Q1
$1.43M Buy
20,777
+8,372
+67% +$530K 0.02% 618
2023
Q4
$918K Sell
12,405
-668
-5% -$43.8K 0.01% 701
2023
Q3
$892K Buy
13,073
+235
+2% +$19.9K 0.01% 682
2023
Q2
$1.21M Buy
12,838
+3,303
+35% +$258K 0.02% 604
2023
Q1
$647K Buy
9,535
+33
+0.3% +$2.12K 0.01% 822
2022
Q4
$470K Buy
9,502
+2,740
+41% +$112K 0.01% 916
2022
Q3
$220K Buy
6,762
+177
+3% +$7.3K ﹤0.01% 1070
2022
Q2
$259K Sell
6,585
-11,927
-64% -$638K 0.01% 1045
2022
Q1
$1.29M Buy
18,512
+339
+2% +$24.8K 0.02% 508
2021
Q4
$1.41M Buy
18,173
+6
+0% +$530 0.02% 488
2021
Q3
$1.73M Sell
18,167
-425
-2% -$44.9K 0.03% 377
2021
Q2
$2.31M Buy
18,592
+5,110
+38% +$610K 0.04% 333
2021
Q1
$1.78M Buy
13,482
+150
+1% +$20.5K 0.04% 341
2020
Q4
$1.77M Sell
13,332
-163
-1% -$19.7K 0.04% 334
2020
Q3
$1.38M Buy
13,495
+57
+0.4% +$4.92K 0.03% 351
2020
Q2
$1.17M Buy
+13,438
New +$1.07M 0.03% 355

Other funds holding EXAS

Xponance's EXAS Position: Q1 2026 in Review

Xponance sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,865 shares — an estimated $1.1M sold.

Xponance first reported a position in EXAS in Q2 2020 and held it in 23 quarters. The position peaked at $2.31M in Q2 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Xponance reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Xponance sold 10,865 Exact Sciences shares in Q1 2026, an estimated $1.1M.
  • Xponance first reported a position in Exact Sciences in Q2 2020 and held it in 23 quarters.
  • Xponance's Exact Sciences position peaked at $2.31M in Q2 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.